ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0058

Health System Improvement in Inpatient ANA and Serologic Test Utilization

Saloni Goyal1, Yasin kanakrieh1, Marie O'Brien1, Amy Slenker1, Kathryn Zaffiri1 and James Ross2, 1Lehigh Valley Health Network, Allentown, PA, 2lvhn, Macungie, PA

Meeting: ACR Convergence 2022

Keywords: comparative effectiveness, Cost-Effectiveness

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Health Services Research Poster I: Lupus, RA, Spondyloarthritis and More

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: In 2005 Lehigh Valley Health Network (LVHN) instituted order sets for ANA serologic reflex testing with the objective to facilitate more efficient patient work-up of a positive ANA. Since then, LVHN continues to offer 3 ANA labs panels including: ANA Alone, ANA with Reflex with ANA > 1:80 reflexed by adding serologic testing, and Comprehensive ANA which includes ANA and at the same time serologic testing. This serologic testing panel includes Sjogren’s antibodies, dsDNA, RNP, Smith, and SCL 70. Benefits of the ANA with Reflex panel include a single visit to the laboratory, and a more rapid cost-effective diagnostic assessment.

The goal of this quality improvement project was to determine ANA panel order frequency and appraisal of educational and EMR interventions for more efficient and cost-effective testing.

Methods: Review of inpatient EMR records found a high frequency of Comprehensive ANA test results with a negative ANA. An education pathway was created that delineated an approach of tests to order starting with ANA with Reflex when suspecting a rheumatological disorder (Fig 1). This was directed towards departments inappropriately ordering more Comprehensive ANA’s: neurology, orthopedics, family medicine and internal medicine. Subsequent data review demonstrated no change in the percentage each of the ANA panel orders. This led to LVHN Test Utilization Committee’s approval for removal of the Comprehensive ANA order from the inpatient EMR for all specialties except rheumatology. The frequency of orders of the ANA with Reflex and Comprehensive ANA were compared for three months before and three the months after this EMR intervention.

Results: This was LVHN’s first appraisal of ANA panel order frequency. The Comprehensive ANA serology was overutilized with 64.98% of Comprehensive ANA ordered being ANA negative, and in these cases the serology panel was unnecessary (Fig 2). The EMR intervention of removing the inpatient Comprehensive ANA resulted in a decrease in the Comprehensive ANA testing with an associated increase in ANA with Reflex. The number of Comprehensive ANA decreased from 181 to 14 and the number of ANA with Reflex increased from 183 to 358. The ANA with reflex became the predominant ANA test ordered at 89% (Fig 3). A small number of Comprehensive ANA panels were ordered by rheumatology. We estimated this inpatient intervention saved the healthcare system $26,000 over 3 months. EMR removal of ANA alone panel has not been implemented yet. The ANA Alone results were approximately 60% normal ANA’s and 40% abnormal.

Conclusion: This quality improvement project detected rheumatic test overutilization and improvement with the removal of the EMR Comprehensive ANA serology panel combined with provider education. LVHN’s approach to ANA testing can be replicated in healthcare systems across the country to reduce cost burden as well as improve efficiency. Our future ANA panel assessments and EMR interventions will focus on improving ANA Alone panels and outpatient ANA testing.

References Tonutti, E., Bizzaro, N., Morozzi, G. et al. The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. Autoimmun Highlights 7, 9 (2016).

Supporting image 1

Figure 1: This pathway delineates the step-wise approach of tests to order when suspecting a rheumatological disorder. It highlights the ANA with reflex as the initial test.

Supporting image 2

Figure 2: Upon review of the total comprehensive ANA ordered the in 2020 and 2021 fiscal year, 64.98% of these tests were negative. These unnecessary tests were the target of this project.

Supporting image 3

Figure 3: This graph displays the frequency of each ANA test before and after intervention. Previously, comprehensive ANA and ANA with reflex both made up the majority of all ANA tests. Following the intervention, the ANA with reflex made up the majority of all ANA tests ordered.


Disclosures: S. Goyal, None; Y. kanakrieh, None; M. O'Brien, None; A. Slenker, None; K. Zaffiri, None; J. Ross, None.

To cite this abstract in AMA style:

Goyal S, kanakrieh Y, O'Brien M, Slenker A, Zaffiri K, Ross J. Health System Improvement in Inpatient ANA and Serologic Test Utilization [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/health-system-improvement-in-inpatient-ana-and-serologic-test-utilization/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-system-improvement-in-inpatient-ana-and-serologic-test-utilization/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology